2Atsunori Tsuchiya,Michitaka Imai,Hiroteru Kamimura,Masaaki Takamura,Satoshi Yamagiwa,Tatsuki Sugiyama,Minoru Nomoto,Toshio Heike,Takashi Nagasawa,Tatsutoshi Nakahata,Yutaka Aoyagi.Increased Susceptibility to Severe Chronic Liver Damage in CXCR4 Conditional Knock-Out Mice[J].Digestive Diseases and Sciences.2012(11)
3Yuichiro Eguchi,Hideyuki Hyogo,Masafumi Ono,Toshihiko Mizuta,Naofumi Ono,Kazuma Fujimoto,Kazuaki Chayama,Toshiji Saibara.Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study[J].Journal of Gastroenterology.2012(5)
4Samantha W. M. Lun,C. K. Wong,Fanny W. S. Ko,David S. C. Hui,Christopher W. K. Lam.Increased Expression of Plasma and CD4+ T Lymphocyte Costimulatory Molecule CD26 in Adult Patients with Allergic Asthma[J].Journal of Clinical Immunology.2007(4)
5Garth H Ballantyne MD, FACS, FASCRS.Peptide YY(1-36) and Peptide YY(3-36): Part II. Changes after Gastrointestinal Surgery and Bariatric Surgery: Part I. Distribution, Release and Actions appeared in the last issue (May 2006)[J].Obesity Surgery.2006(6)
6Garth H Ballantyne MD, FACS, FASCRS.Peptide YY(1-36) and Peptide YY(3-36): Part I. Distribution, Release and Actions[J].Obesity Surgery.2006(5)
7J. J. Holst.Glucagon-like peptide-1: from extract to agent. The Claude Bernard Lecture, 2005[J].Diabetologia.2006(2)
8V?in? K. Hopsu-Havu,George G. Glenner.A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-β-naphthylamide[J].Histochemie.1966(3)
